In this week’s Research Ethics Roundup, we explore some of the ethical and practical questions posed by new innovations in the research enterprise, as well as some age old concerns, such as the recruitment of subjects for clinical trials. Read on:
FDA, Sponsors Look to Expand Patient Input to Clinical Trials: The involvement of patient groups in the design of clinical trials is becoming increasingly common. In this article for Applied Clinical Trials, Jill Wechsler reports on this shift, as well as the Food and Drug Administration’s efforts to foster patient-focused drug development.
Hopkins Faces $1B Lawsuit Over Role in Government Study that Gave Subjects STDs: From 1946 to 1948, the US Public Health Service supported research in Guatemala in which subjects were intentionally exposed and infected with sexually transmitted diseases without consent. On April 1, former research subjects and their families filed a lawsuit against The Johns Hopkins University, which alleges that the institution is in part responsible given the role that some faculty members at the institution had in approving the study.
Living With Cancer: Clinical Trials Looking for Patients: In this column for The New York Times, Susan Gubar examines clinical trial enrollment through her own experiences participating in a Phase I trial for ovarian cancer, including how the design of trials make participation difficult for many.
This New Facebook App Wants to Collect Your DNA for Research: Genes for Good, a new Facebook app from the University of Michigan, will allow individuals to “complete recurring surveys about their health history and habits.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.